Beta Blocker ODRegister Today!
- by nursenancy27 Jul 11Hello all,
We recently had a patient on our unit who had OD'd on beta blockers and one of the treatments was high dose insulin. I'm curious if anyone has experience with this and could explain the mechanism of action for how this would help. Thanks!
- Jul 12 by akulahawkI found an article that may answer your question: High-dose insulin therapy in beta-block... [Clin Toxicol (Phila). 2011] - PubMed - NCBI
- Jul 12 by DodongoInsulin has positive inotropic effects - as does glucagon, which is great for countering the negative effects of a BB overdose.
- Jul 12 by akulahawkGlucagon does work. However, according to the article, high dose insulin with glucose therapy seems to be superior to conventional therapies for certain OD's, such as these. If this is proven to work well, and is superior to conventional therapies, I can see lots of insulin/glucose in the future... but not on ambulances. Glucagon will still rule the roost in that environment because Glucagon tolerates a wider range of temperatures.
The article specifically cited insulin's positive inotropic properties. Interesting!
- Jul 15 by Esme12They are both used .......although there is some evidence that high does insulin is the preferred method.High-dose insulin
In case reports and animal models, high-dose insulin infusion has been reported to improve outcomes in beta-blocker poisoning, as well as in calcium-channel blocker poisoning. The mechanism of action is via the positive inotropic effects of insulin.
The optimal regimen is still to be determined. The currently recommended regimen is a 1 U/kg of an insulin bolus followed by continuous infusion of 1-10 U/kg/h, but boluses of up to 10 U/kg and continuous infusions as high as 22 U/kg/h have been used with good outcomes and minimal adverse events.
After consultation with a medical toxicologist, this treatment should be considered for overdoses that are refractory to crystalloids, glucagon, and catecholamine infusions. Of note, because of the risk of iatrogenic hypoglycemia and hypokalemia, the clinician must be particularly vigilant in monitoring these patients' serum glucose and potassium levels.
and my favorite site...medscape....Beta-Blocker Toxicity medscape requires registration but is an excellent source.....AND IT"S FREE!!!
Medscape: Medscape Access